These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
6. [Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus]. Guillon J; Charbonnel B Cah Med; 1972 Nov; 13(14):999-1006. PubMed ID: 4646244 [No Abstract] [Full Text] [Related]
7. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus]. Villaseñor A Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089 [No Abstract] [Full Text] [Related]
8. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
9. [Oral antidiabetics]. Bäbler M Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095 [No Abstract] [Full Text] [Related]
10. The oral hypoglycaemic agents reassess. Drug Ther Bull; 1974 Mar; 12(5):17-20. PubMed ID: 4820614 [No Abstract] [Full Text] [Related]
11. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea. Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060 [No Abstract] [Full Text] [Related]
12. [Long term efficacy and tolerance of antidiabetic treatments. New data]. Mirouze J Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493 [No Abstract] [Full Text] [Related]
13. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]. Ninni M; Castelletta L Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364 [No Abstract] [Full Text] [Related]
14. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide. D'Onofrio F; Pempinello R; Romis L Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059 [No Abstract] [Full Text] [Related]
15. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE]. Jaillard J; Warembourg H Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429 [No Abstract] [Full Text] [Related]
16. [Oral antidiabetics of the sulfonylurea group and their problems in therapy]. Füsgen I; Summa JD Z Gerontol; 1980; 13(1):45-51. PubMed ID: 7456613 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024. Parodi FA Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831 [No Abstract] [Full Text] [Related]
18. [Recent development in the diabetes-therapy]. Landgraf R; Dieterle C Internist (Berl); 1977 Oct; 18(10):509-19. PubMed ID: 412809 [No Abstract] [Full Text] [Related]
19. [Experimental and clinical pharmacology of oral antidiabetics]. Cuomo V; Marino A Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507 [No Abstract] [Full Text] [Related]
20. [Diamicron]. Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568 [No Abstract] [Full Text] [Related] [Next] [New Search]